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Abstract
Background: Molecular techniques have uncovered vast numbers of organisms in
the cystic fibrosis (CF) airways, the clinical significance of which is yet to be
determined. The aim of this study was to describe and compare the microbial
communities of the lower airway of clinically stable children with CF and children
without CF.
Methods: Bronchoalveolar lavage (BAL) fluid and paired oropharyngeal swabs
from clinically stable children with CF (n513) and BAL from children without CF
(n59) were collected. DNA was isolated, the 16S rRNA regions amplified,
fragmented, biotinylated and hybridised to a 16S rRNA microarray. Patient medical
and demographic information was recorded and standard microbiological culture
was performed.
Results: A diverse bacterial community was detected in the lower airways of
children with CF and children without CF. The airway microbiome of clinically stable
children with CF and children without CF were significantly different as measured
by Shannon’s Diversity Indices (p50.001; t test) and Principle coordinate analysis
(p50.01; Adonis test). Overall the CF airway microbial community was more
variable and had a less even distribution than the microbial community in the
airways of children without CF. We highlighted several bacteria of interest,
particularly Prevotella veroralis, CW040 and a Corynebacterium, which were of
significantly differential abundance between the CF and non-CF lower airways.
Both Pseudomonas aeruginosa and Streptococcus pneumoniae culture abundance
were found to be associated with CF airway microbial community structure. The CF
upper and lower airways were found to have a broadly similar microbial milieu.
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Conclusion: The microbial communities in the lower airways of stable children with
CF and children without CF show significant differences in overall diversity. These
discrepancies indicate a disruption of the airway microflora occurring early in life in
children with CF.
Introduction
The long held concept that the lower airway is a sterile environment has been
challenged recently [1, 2]. New molecular techniques are not only demonstrating
the presence of organisms where previously there were considered to be none, but
are finding a large variety of taxa present at any one time in the ‘‘normal’’ lung [1–
3]. In the respiratory tract, as in other organ systems, there appears to be a more
diverse array of organisms in health than in disease [1, 4, 5]. These challenging
discoveries are forcing a paradigm shift in our approach to understanding the
concepts of colonisation and infection in the lung. We are now faced not simply
with an infecting pathogen, but instead with a diverse community of organisms
where disease may be defined by the makeup and relative abundance of the
members of the microbial community [6].
The evolution of the airway microbiome in cystic fibrosis (CF) and its
relationship to lung disease progression is still poorly understood. Traditionally,
CF antimicrobial therapy has been directed against a small number of common
pathogens detected by standard culture. Recent evidence has revealed hundreds of
bacteria to be present in the CF airways [7, 8], raising questions about the
relevance of current diagnostic methods. A considerable variation in species’ drug
susceptibility [9–11] and virulence [12] is likely to exist in these microbial
communities and directing anti-microbial therapy towards one or two pathogens
has unknown consequences on the remaining microbial community. Cross-
sectional and longitudinal studies examining the impact of antibiotics on the CF
airway microbiome have reported an association between antibiotic exposure and
a transient decrease in microbiome diversity [6, 13]. However microbial
community structures in the CF airway have been reported to return to pre-
exacerbation compositions within four weeks of antibiotic treatment and
furthermore airway microbial community structures within individual CF
patients have been shown to be resilient over time despite antibiotic treatment
[14]. The types of species present in the airway microbial community and the
relative abundance of these species may be as important as the presence or absence
of common pathogens in the CF airway.
Our study employed a 16S rRNA microarray to describe and compare the
microbial community in the lower airways of children with CF and without CF
(controls) in an attempt to understand more clearly the abnormal microbiological
milieu in the CF airway. An increase in our understanding of this complex area
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may help us to discover more relevant diagnostic tests and develop more
appropriate antimicrobial regimes for children with CF.
Materials and Methods
Ethics Statement
Ethical approval for this study was granted by Our Lady’s Children’s Hospital
Crumlin research ethics committee (reference number GEN/210/11) and
informed consent was obtained from the parents or guardians of all participating
subjects.
Patient Group
Infants and young children were recruited through the Study of Host Immunity
and Early Lung Disease in CF (SHIELD CF), a longitudinal study established
around a preschool bronchoalveolar (BAL) surveillance programme at our
institutions. This involves performing bronchoscopy and BAL on clinically stable
children up to the age of 6 years (or until the child is expectorating) as part of an
annual review. Stability was defined as no change in respiratory symptoms from
baseline or use of antibiotics for infective exacerbations within 3 weeks of the
procedure. Patients in this study were recruited over a 13 month period between
October 2010 and November 2011.
Children without CF undergoing bronchoscopy for clinical reasons, such as
prior haemoptysis or stridor, were also recruited. These children were clinically
well at the time of the procedure. The BAL samples from this control cohort were
included for comparison if the differential cell count in BAL was normal.
BAL and Oropharyngeal Swab Collection and Storage
Flexible fibreoptic bronchoscopy was performed via a laryngeal mask airway
under general anaesthetic. To prevent upper airway contamination, suction was
not performed until the tip of the bronchoscope was past the carina. BAL was
performed by instilling 1 ml/kg sterile 0.9% saline (w/v) per aliquot and retrieved
using low pressure suction. The BAL was performed twice in the right middle lobe
and twice in the lingula. All four samples were then pooled. BAL was immediately
sealed in a sterile container, put on ice and transported to the laboratory. An
aliquot of BAL fluid was sent directly for standard microbiological testing. The
remaining BAL fluid was split and one part treated with two volumes of RNALater
(Qiagen). The remainder was processed as follows: Total cell counts were
performed using trypan blue exclusion and differential cell counts were carried
out manually on cytospin preparations of BAL by light microscopy. BAL was
subsequently centrifuged at 1,0576g and the supernatant aliquoted and frozen at
280 C˚ for subsequent experiments. Oropharyngeal swabs (SWB) were collected
using a sterile double-tipped swab (BBL CultureSwab, Becton, Dickinson) by a CF
nurse specialist experienced in the procedure. One tip was sent for standard
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culture and the other tip was suspended in 2 ml RNALater. Samples were then
stored at 280 C˚.
Standard Microbiological Culturing
Health Protection Agency protocols were adhered to for all microbiological
testing. Selective media for the detection and enumeration of Staphylococcus
aureus (Colistin DNase Mannitol agar), Methicillin resistant S. aureus (salt
enrichment broth), Burkholderia cepacia (Burkholderia cepacia selective agar),
Haemophilus influenzae (Bacitracin chocolate agar) and Pseudomonas aeruginosa
(Cetrimide agar) were employed. Additionally, chromogenic selective agar, blood
agar, chocolate agar and MacConkey agar were used to identify additional species
such as Streptococcus pneumoniae, Candida species and Moraxella catarrhalis. To
provide semi-quantitative information and to provide a standard system for
comparing culture data to microbiome diversity, growth was scored as absent (0),
1 to 100 CFU/ml (1), 100 to 10,000 CFU/ml (2) or .10,000 CFU/ml (3).
Isolation and Quantification of DNA from BAL and SWB
Frozen BAL samples were thawed on ice and centrifuged for 10 min at 10,0006g.
SWB samples were thawed, mixed by inverting and centrifuged for 10 min at
10,0006g. The pelleted material was then resuspended in 600 ml of buffer RLT
(Qiagen DNA/RNA AllPrep Mini kit) and bead beating performed (0.3 g of
180 mm acid washed glass beads; Sigma Aldrich) for 30 sec at 5.5 m sec21.
Supernatant was transferred to a Qiagen DNA spin column and DNA extracted
using the Qiagen DNA/RNA AllPrep Mini kit. DNA quantity was determined
using the Quant-iT PicoGreen dsDNA assay kit (Invitrogen) following the
manufacturer’s instructions. A negative control was included where the entire
DNA extraction process was performed with 1 ml of 0.9% saline (w/v) as the start
material. No DNA was isolated from the 0.9% saline (w/v) however 16S rRNA
amplification was still performed on this negative control.
Amplification of the 16S rRNA region
The bacterial 16S rRNA region was amplified using universal 16S rRNA primers
27F (59-AGAGTTTGATCCTGGCTCAG-39) and 1492R (59-
GGTTACCTTGTTACGACTT-39) as previously described [7]. Each sample and
the negative control was amplified in four replicate reactions over a range of
annealing temperatures. Thermal cycling parameters were as follows; 95 C˚ for
3 min for 1 cycle followed by 30 cycles of 95 C˚ for 30 sec, 46–56 C˚ for 25 sec,
72 C˚ for 2 min and a final extension step of 72 C˚ for 10 min. For each sample,
amplicons were pooled, purified with the QIAquick PCR purification kit (Qiagen,
Valencia, CA), concentrated using the solid-phase reversible immobilization
method and quantified by electrophoresis (Agilent 2100 Bioanalyzer). The 0.9%
saline (w/v) negative control yielded no 16S rRNA PCR amplicon. Phylochip
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Control Mix was added to each amplified product allowing quantitative
interpretation of the relative abundance of taxa.
Phylochip Microarray
For the analysis of bacterial communities the G3 Phylochip Array (Second
Genome, San Bruno, CA) was employed. A full description of the Phylochip
design is provided in the supplementary methods of Hazen et al. [15] and are
briefly outlined here in S1 File: Supplementary Methods. Ribosomal PCR
products were DNAase fragmented, biotin labelled, and hybridized to the G3
Phylochip Array, then washed, stained, and scanned using a GeneArray scanner
(Affymetrix) as previously described [15].
Microarray Data Processing
The summary intensity for each feature on each array was calculated by ranking
the central 9 pixels of individual features by intensity and the 75th percentile was
used. Probe intensities were background-subtracted within each of the 25 separate
physical sectors and scaled to the Phylochip Control Mix. Array fluorescence
intensities were collected as integer values ranging from 0 to 65,536 (216).
Presence/Absence scoring was conducted according to the positive fraction
approach. Noise (N) for each array was calculated according to DeSantis 2007
[16]. For each taxa represented on the Phylochip a perfectly matched (PM) probe
and mismatched (MM) probe were incorporated. A PM probe is complementary
to the target sequence, whereas the MM probe is identical in all of the 25
nucleotide positions except the thirteenth base. Fluorescence intensity from PM
and MM probes were compared and considered ‘‘positive’’ when PM-MM
.550*N and PM/MM .51.5. PM fluorescence intensities from 73,959 probes
observed as positive in at least 3 experiments were exported from all experiments
then ranked within each sample and used as input to empirical probe-set
discovery by cluster analysis. Probes were clustered into probe-sets or empirical
Operation Taxonomic Unit (eOTU) based on both correlations in fluorescence
intensities across all biological samples and taxonomic relatedness. Where
multiple clustering solutions were available, higher correlation coefficients were
favoured over lower coefficients, taxonomic relatedness at the species level was
favoured over higher ranks, and sets composed of more probes were favoured
over less. All probe sets contained .57 probes, with average pair-wise correlation
coefficients .50.85. The eOTU tracked by a probe set was taxonomically
annotated from the combination of the 9-mers contained in all probes of the set.
The mean ranked fluorescence intensity for each eOTU and each sample was
calculated. These values are referred to as the hybridization scores (HybScore)
used in abundance-based analysis. eOTUs were considered present in a sample if
.580% of their probes were positive for that sample. A more detailed description
of the microarray data processing and data reduction is in S1 File: Supplementary
Methods.
The Lower CF Airway Microbiome
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Microarray Data Analysis
Microbial communities are profiled and compared based on diversity. Microbial
communities can be described based on the number of taxa present (richness), the
quantity of the bacterial taxa present (abundance) and the relative abundance of
the taxa present (evenness). After the taxa are identified for inclusion in the
analysis, the values used for each taxa-sample intersection are populated in two
distinct ways; the abundance metrics and the incidence metrics. Taxa are then
filtered to those present in at least one of the samples or to taxa significantly
increased in their abundance in one category compared to the alternate categories.
For the latter filter, the parametric Welch test was employed to calculate p-values.
Additionally, q-values were calculated using the Benjamini-Hochberg procedure
to correct p-values, controlling for false discovery rates. Multiple testing was also
accounted for using permutation tests.
To compare sample-to-sample distances, profiles were inter-compared in a
pair-wise fashion to determine a dissimilarity score which was stored in a distance
dissimilarity matrix. The distance functions were chosen to allow similar
biological samples to produce only small dissimilarity scores. The UniFrac
distance metric [17], which utilizes the phylogenetic distance between eOTUs, was
used to determine the dissimilarity between communities. Additionally, Weighted
Unifrac was employed to consider eOTU abundance. Principal Coordinate
Analysis (PCoA) biplots were constructed using UniFrac and weighted UniFrac
dissimilarity matrices to visualize complex relationships between samples. The
Adonis test, a Monte Carlo permutation test, was performed on distance matrices
to compare the between category differences of randomly reassigned sample
categories to the true categories. M Diversity indices such as the Shannon’s
Diversity Index (SDI) provide a mathematical measure for describing the diversity
of a community taking in to consideration species richness and differences in
abundances for each species across samples [18]. The proportion of a species
relative to the total number of species is computed as the ratio of the species
HybScore to the sum of HybScores. In molecular profiling, the relative value of
the SDI is compared between sample groups to infer differences in underlying
microbial community. Microsoft Excel was used to calculate the SDI of the
microbial community present in each sample.
To construct the circular tree, a Welch test was performed across the groups of
samples using the abundance metrics. Those taxa significantly below the threshold
(p,0.05) were grouped into families and the one taxon from each family (plus
one if a family contained eOTUs that significantly increased and decreased in
abundance between categories) with the greatest difference between the two group
means was selected for inclusion in the circular tree. 59 taxa from 51 families had
significantly increased or decreased abundance in one of the comparison groups.
The tree, taxonomy labels and abundance data were rendered in iTOL. The
Adonis test was then used to find significant differences among discrete
categorical or continuous variables (age, sex, P. aeruginosa, H. influenzae, S.
pneumoniae, M. catarrhalis, Candida). The PhyCA-Stats analysis software package
The Lower CF Airway Microbiome
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was used for multivariate analysis and R software version 3.0.1 was used to carry
out all other analysis.
The raw hybridisation data, processed hybridisation data (abundance metrics
and binary metrics), eOTU annotations and metadata associated with this study
were deposited in Greengenes database and can be accessed at the following link
http://greengenes.secondgenome.com/downloads/phylochip_datasets.
Results
Thirteen clinically stable children with CF and nine control children were
recruited. Baseline clinical characteristics of the study group are presented in
Table 1. The mean age of the CF patient cohort was 3.95 years (ranging 1.1 to 8.1
years) and the mean age of the non-CF patient cohort was 3.78 years (ranging 0.9
to 9.75 years). All CF patients had no change in respiratory symptoms from
baseline and were not receiving antibiotics for up to three weeks prior to
bronchoscopy. All non-CF control patients were clinically well at the time of
bronchoscopy and had baseline normal differential cell count in BALs (as
compared to historical true controls; data not shown).
The control and CF lower airway microbial communities differ
significantly while the upper and lower CF airway communities
are similar
A total of 73,959 probe pairs were positive over our patient population. From this
1,269 were detected in at least one sample using the microarray. An average of 167
species (ranging 145 to 202) were identified from the control lower airway, 133
species (ranging 67 to 163) from the CF lower airway and 130 species (ranging 71
to 167) from the CF upper airway. In descending order, the phyla accounting for
the majority of the fluorescence intensity were Proteobacteria, Firmicutes,
Bacteroidetes, an unclassified bacterial Phylum and Tenericutes. The genera
accounting for the majority of the fluorescence intensity were an unclassified
Lachnospiraceae genus, an unclassified Rikenellaceaell genus, Pseudomonas,
Streptococcus and Prevotella.
SDI’s were calculated for each sample and used to compare overall diversity of
the three study groups. The control lower airway bacterial community was
significantly more diverse than that of the CF lower airway (p50.001;
heteroscadastic, two-tailed t-test). The CF upper and lower airway microbiome
did not differ significantly in their overall diversity (p50.534; heteroscadastic,
two-tailed t-test) (Fig. 1).
Principal Coordinate Analysis (PCoA) is a method of two-dimensional
ordination plotting that is used to visualize complex relationships between
samples. PCoA uses dissimilarity values generated by calculating distance
measures to position the points relative to each other on a bi-plot. Separate
distance matrices based on taxa presence/absence and taxa abundance were
The Lower CF Airway Microbiome
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constructed for each patient cohort and UniFrac and weighted UniFrac distance
measures, respectively, were used to plot the dissimilarity between microbial
communities on PCoA bi-plots. The Adonis test was performed on distance
matrices to compare the between category differences of randomly reassigned
sample categories to the true categories. The airway bacterial communities from
our three categories differ significantly based on taxa present (p50.015) (Fig. 2A)
and on taxa abundance (p50.020) (Fig. 2B). Additional Adonis tests were
performed to compare the individual groups. The control lower and CF lower
airway samples grouped significantly based on taxa present (p50.01), however the
CF lower and CF upper airway samples did not group significantly based on taxa
present (p50.292) or taxa abundance (p50.116). These results demonstrate that
the CF airway microbial community structure is disrupted from the control state.
These results also reveal that the structure of the microbial community in the CF
Table 1. Baseline demographic and clinical characteristics of all patients included in the study.
Patient
number CF/Control
Sex (M/
F)
Age
(years) CFTR mutation Culture data (0 to 3)
Medications/supplements at
time of bronchoscopy
PA SP MC SA HI NF
1 CF M 2.18 DF508/DF508 0 0 0 0 0 3 Creon, vitamins, Omeprazole,
HS
2 CF F 5.3 DF508/DF508 0 0 0 1 3 1 Creon, vitamins, HS
3 CF M 3.75 DF508/DF508 0 0 0 0 0 1 Creon, vitamins, HS
4 CF F 1.1 DF508/DF508 2 0 0 0 0 1 Creon, vitamins
5 CF F 5.6 DF508/DF508 0 0 0 0 0 2 Creon, vitamins, HS
6 CF M 3.25 DF508/DF508 0 0 0 0 2 1 Creon, vitamins, HS
7 CF M 4.7 DF508/DF508 0 1 0 1 1 1 Creon, vitamins, HS
8 CF M 3 DF508/DF508 0 0 1 0 1 1 Creon, vitamins, HS, DNAse
9 CF M 3.25 DF508/DF508 0 0 0 0 3 1 Creon, vitamins
10 CF M 2.85 DF508/DF508 3 2 0 0 0 1 Creon, vitamins
11 CF M 5.3 DF508/2184DelA 0 0 0 0 3 1 Creon, vitamins, HS
12 CF M 8.1 DF508/DF508 0 0 0 1 1 2 Creon, vitamins, HS
13 CF F 3 DF508/DF508 0 0 0 0 0 3 Creon, vitamins, HS
14 Control F 1.7 N/A 0 0 2 1 2 0 No medication
15 Control F 2 N/A 0 0 0 0 0 0 No medication
16 Control F 2 N/A 0 3 0 0 3 1 ICS
17 Control F 8 N/A 0 0 0 0 1 1 No medication
18 Control F 1.92 N/A 0 0 0 0 3 1 No medication
19 Control M 4 N/A 0 0 0 0 3 1 ICS
20 Control M 0.9 N/A 0 0 0 0 1 1 No medication
21 Control M 9.75 N/A 0 0 0 0 0 1 No medication
22 Control F 3.75 N/A 0 0 0 0 3 1 ICS
PA 5 Pseudomonas aeruginosa, SP 5 Streptococcus pneumoniae, MC 5 Moraxella Catarrhalis, SA 5 Staphylococcus aureus, HI 5 Haemophilus
influenzae, NF 5 Normal Flora, ICS 5 Inhaled corticosteroids, HS 5 Hypertonic Saline.
050 CFU/ml, 151 to 100 CFU/ml, 25100 to 10,000 CFU/ml and 35.10,000 CFU/ml.
doi:10.1371/journal.pone.0109798.t001
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upper and lower airways are broadly similar, suggesting that both specimens may
be valid representatives of the CF airway microbial community.
Taxa of significance between the control and CF lower airway
microbial communities
There were 237 taxa found to be present in significantly different abundance
between the control and CF lower airways using the Welch test (p,0.05) (S2 File).
Fifty-nine eOTUs within 50 families were significantly different (p,0.05) in one
of the comparison groups (Fig. 3). When the Benjamini-Hochberg procedure was
performed to adjust for multiple testing, only 2 eOTUs remained significant
(q,0.05); Prevotella veroralis within the Bacteroidetes phylum and CW040 within
the TM7 phylum. Both of these eOTUs were significantly less abundant in the CF
airway. The Benjamini-Hochberg procedure is a harsh method for adjusting for
multiple testing therefore a permutation test was performed to determine how
many of the 237 eOTUs would pass the Welch test at p,0.05 by randomizing the
abundance table 100 times (S3 File). Following this randomized permutation test
the median randomization found 41 eOTUs as significantly different, far fewer
than the 237 eOTUs that were found in the real data. The ‘‘best’’ result from the
randomized data was 175 eOTUs. Therefore the 62 eOTUs with the lowest p-
values were considered to be of significantly differential abundance between the
control and CF lower airway (S2 File). From these eOTUs, a Corynebacterium was
found to be more abundant in the CF airway than in the control airway following
the permutation test (Fig. 3). Other genera found to be of significantly differential
Fig. 1. Richness of the microbial communities present in the control lower airways and the CF upper
and lower airways. Box and Whiskers plot of Shannon’s diversity indices for microbial communities present
in the control lower airway, CF lower airway and the CF upper airway. * represents statistical significance
(p50.001; two-tailed t test).
doi:10.1371/journal.pone.0109798.g001
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Fig. 2. Bacterial community structures in the control lower airways and the CF upper and lower
airways. Principle coordinate analysis (PCoA) plots of A) UniFrac distances and B) weighted UniFrac
distances of all airway microbial communities were created in R. Each community from each sample is
represented as a filled circle and coloured by sample type and/or patient cohort; CF lower (CF BAL; red), CF
upper (CF SWB; blue) and control lower (CN BAL; yellow) airway samples. The x-axis and y-axis represent 2-
dimensions of percentage variation explained by the PCoA. Ellipses were included for visualisation purposes.
doi:10.1371/journal.pone.0109798.g002
The Lower CF Airway Microbiome
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Fig. 3. Taxa of differential abundance between the control and CF lower airway. Circular Phylogenetic Tree was rendered in iToL and illustrates
abundance changes between eOTUs present in the control lower (inner ring) and CF lower (outer ring) airways. The colour saturation indicates the degree of
difference from the mean control lower value for the eOTU; where dark blue indicates a HybScore difference of 252326, white 50 (no change from mean
control lower), dark red5+61480. Two eOTUs remained of significantly differential abundance following Benjamini-Hochberg correction; Prevotella veroralis
(*) and a CW040 (**). Following a permutation test, 62 taxa were found to be of significantly differential abundance, Corynebacterium (***) is highlighted. A
detailed list of the 59 taxa of significantly differential abundance between categories is provided in the supplementary data (S2 File).
doi:10.1371/journal.pone.0109798.g003
The Lower CF Airway Microbiome
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abundance between the control and CF airway were Prevotella, Bacteroides,
Pseudomonas, Streptobacillus, Actinomyces, Selenomonas, Blautia and Leptotrichia.
The individual eOTUs were investigated for their specific alliance with one or
the other category (CF and control). In total, 58 eOTUs were found to be present
in .30% of one category while being completely absent from the other category
(S4 File). A Streptococcus sp, an unclassified Bacteria and a Corynebacterium sp
were present in .46% of CF lower airway samples while completely absent from
the control lower airway samples (Table 2). A Pseudomonas sp, three unclassified
Lachnospiraceae and Peptostreptococcus anaerobius were present in .44% of the
control airway samples while absent from the CF airway samples. While 4 eOTUs,
including Prevotella veroralis, were found to be present in all but three control
lower airway samples but absent in all CF lower airway samples (Table 2). The
bacteria highlighted in this section may describe the major niches of disruption
that cause an imbalance of the CF airway microbial community.
Bioburden of Pseudomonas aeruginosa and Streptococcus
pneumoniae, as determined by culture, was associated with
bacterial community diversity
P. aeruginosa and S. pneumoniae presence and burden, as quantified by culture,
were the only discrete variables associated with overall bacterial community
Table 2. eOTUs present in one category and absent from the other.
Phylum Family Genus Species
Present in
control (%)
Present in CF
(%)
Proteobacteria Procobacterieceae Procobacter Unclassified 0 38.5
Tenericutes Acholeplasmataceae Candidatus Candidatus phytoplasma 0 38.5
Bacteroidetes Unclassified Unclassified Unclassified 0 38.5
Firmicutes Streptococcaceae Streptococcus Unclassified 0 46
Unclassified Unclassified Unclassified Unclassified 0 46
Actinobacteria Corynebactericeae Corynebacterium Unclassified 0 46
Firmicutes Lachnospiriceae Unclassified Unclassified 55.6 0
Bacteriodetes Rickenellaceaell Unclassified Unclassified 55.6 0
Proteobacteria Pseudomonaceae Pseudomonas Unclassified 55.6 0
Unclassified Unclassified Unclassified Unclassified 55.6 0
Proteobacteria Comamonadaceae Diaphorobacter Unclassified 55.6 0
Firmicutes Veillonellaceae Unclassified Unclassified 55.6 0
Fusobacteria Fusobactericeae Leptotrichia Unclassified 55.6 0
Firmicutes Veillonellaceae Selenomonas Unclassified 55.6 0
TM7 F16 Unclassified Unclassified 55.6 0
Actinobacteria Actinomycetaceae Actinomyces Unclassified 66.7 0
TM7 Unclassified Unclassified Unclassified 66.7 0
Proteobacteria Unclassified Unclassified Unclassified 66.7 0
Bacteroidetes Prevotellaceae Prevotella Prevotella veroralis 77.8 0
doi:10.1371/journal.pone.0109798.t002
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diversity in the CF lower airways (Table 3). An Adonis test was performed using
the UniFrac distance matrix and weighted UniFrac distance matrix to determine if
samples with dissimilar S. pneumoniae and P. aeruginosa culture scores were
dissimilar in their whole microbiome profile. CF patients with dissimilar P.
aeruginosa culture scores had significantly dissimilar microbial community
structure (p50.011 and p50.009 for community evenness and richness
respectively). Likewise, CF patients with dissimilar S. pneumoniae culture scores
had dissimilar microbial community structure (p50.035 for community
richness). Age was not associated with community diversity in the CF airway
which has been noted previously [6] however our patient cohort was of a young
age only. From this study it was also noted that the Pseudomonas and Haemophilus
genera had an inverse correlation (r520.703) across all samples in the study as
measured by Pearson’s correlation analysis on the sum of HybScores for all
eOTUs belonging to these two genera. This suggests that these two genera may be
competitors in the airway microbiome.
Discussion
Here we describe the microbial milieu of the lower airways of clinically stable
children with CF and compare it to the microbial community present in children
without CF. We have demonstrated a degree of dissimilarity between the CF
airway and control airway and have isolated key differences that suggest early signs
of disruption in the homeostasis of the CF airway microbial flora.
Microbial diversity measured in sputum from adults with CF has been shown
to be significantly reduced when compared to controls [19]. Our results
corroborate these findings in BAL from clinically stable patient populations under
10 years of age, suggesting that the microbial community of the CF airway is
fundamentally disrupted from an early age. Klepac-Ceraj et al. demonstrated an
inverse correlation between sputum community complexity and age [7]. Here we
did not see such correlations however this may not be evident in such a young
patient cohort.
We found the Proteobacteria, Firmicutes, Bacteroidetes, an unclassified phylum
and Tenericutes phyla to account for the majority of HybScores in the lower
airways of children with CF. The major phyla identified in this study are
consistent with other studies looking at sputum samples in individuals with CF
[6, 7]. The same phyla were found to account for the majority of HybScores in the
control airway microbial community. Three of these phyla, Firmicutes,
Proteobacteria and Bacteroidetes, were previously reported to be the most
abundant phyla in the healthy adult airway [1], suggesting that the same phyla
may dominate the airways from childhood through to adulthood in healthy
individuals, with Tenericutes possibly being more dominant in the airways in
early childhood. At the genera level, an unclassified Lachnospiraceae genus, an
unclassified Rikenellaceaell genus, Pseudomonas, Streptococcus and Prevotella were
found to account for the majority of HybScores in the airways of children with CF
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and children without CF. Direct comparisons between different studies in this
field can be challenging as studies often differ in the type of sample collected
(oropharyngeal swabs [6], sputum [7, 20], BAL [21], explanted lung biopsies
[22]), the age of patients recruited [6, 7, 21], the clinical status of patients at the
time of sampling [14, 23–25], differential coverage of the 16s rRNA region, the
metagenomic technique employed [6, 26, 27] and ultimately the taxonomic and
analytical tools used to assign OTUs and interpret the data. All of these factors will
influence the phylogenetic diversity reported.
The CF airway microbial community displayed a less rich and less even
community distribution than the control airway microbial community. This
suggests a level of symmetry in the control airways, not seen in the early CF airway
microbial community. A high level of intrapatient variability of the CF airway
microbial community has been reported in adult CF patients by Stressmann, F. A.
et al [28]. Our young clinically stable patient cohort has revealed that this high
intrapatient variability in microbial community structure is also evident very early
in the life of CF patients. Taken together, this suggests that the microbial
community in the airways of CF patients is unique to that patient and this unique
or ‘‘personalized’’ airway microbial community emerges early in life.
We identified a number of bacterial taxa that were of significantly differential
abundance between the control and CF lower airway. Prevotella veroralis is a Gram
negative bacterium known to be present in the oral cavity of healthy individuals
[29] and, in the present study, was found to be significantly less abundant or
absent from the CF airway. P. veroralis has been identified previously in the
airways of clinically stable CF adults [25, 30] however we found this bacteria to be
absent from the airways of clinically stable children with CF. Another bacterium
highlighted in this study was a Corynebacterium found to be in significantly higher
abundance in the CF airway than in the control airway. Corynebacterium are Gram
positive bacteria that are found in the environment and as part of the microflora
of the human skin and mucous membranes, and certain members of this genus
have been shown to become pathogenic under certain conditions. In particular,
Corynebacterium species have been found to cause respiratory infections in
children with CF [31]. The bacterial taxa outlined in this study may be descriptive
of the primary discrepancies between the commensal microbial community of the
healthy airways and that present in the CF airways.
Previous studies have shown the influence of P. aeruginosa on the CF airway
microbiome. Klepac-ceraj and colleagues [6] noted that CF airway microbial
communities dominated by P. aeruginosa were less diverse. Here we observed that
CF patients with dissimilar P. aeruginosa culture scores had significantly dissimilar
microbial community structures. Likewise, CF patients with dissimilar S.
pneumoniae culture scores had dissimilar microbial community structures. These
findings suggest that P. aeruginosa and S. pneumoniae may significantly influence
the composition of the early CF airway microbial community. The influence of S.
pneumoniae on the CF airway microbiome has not been reported before. The
presence of other common CF bacteria such as M. catarrhalis, S. aureus, and H.
influenzae, as detected by culture, did not influence community structure.
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Pseudomonas and Haemophilus were observed to have an inverse correlation
across all airway samples suggesting these may be competing genera in the lungs.
Most preschool children with CF do not expectorate sputum, therefore cultures
of upper airway throat swabs are routinely used to direct therapy towards lower
airway infection. The suitability of upper airway oropharyngeal swabs as
surrogates for lower airway BAL samples has long been in debate. In the present
study we collected paired oropharyngeal swabs and BAL samples from 12 CF
patients and compared the bacterial community’s detected employing Phylochip
analysis. We found the CF upper and lower airway microbial communities to be
representative of each other. This is in agreement with a previously published
study where the microbial communities from oropharyngeal swabs and BAL of a
subset of children with CF were compared and found to be concordant [6].
Goddard, F. A and colleagues recently published a contradictory study where they
found upper airway throat swabs and sputum samples to overestimate the
diversity of the CF lower airway [22]. However, complementary analysis of the
relative abundance data from the Goddard, F. A. study revealed a broadly similar
microbial community in the upper and lower airway [32]. Although every attempt
was made in the present study to eliminate upper airway bacterial contamination
during collection of BAL samples, this cannot be ruled out as a possible reason for
the similarities observed in the CF upper and lower microbial communities. The
fact that the upper and lower airways are biogeographically close sites should also
not be ruled out as a reason for similarities in the microbial communities that
populate these sites [33]. We also observed that standard culture of upper airway
samples failed to detect bacteria cultivable from several lower airway samples
(data not shown). This demonstrates that culture of upper airway swabs may not
accurately represent the bacteria present in the lower airway of CF patients and
this remains an area of uncertainty.
The G3 Phylochip detected many more bacterial species than was detected by
standard culture. This is unsurprising as culture methods are designed to select for
the growth of a narrow range of well-known CF pathogens. In contrast, the G3
Table 3. Adonis scores for correlations between CF community diversity and discrete variables.
Variable Community evenness Community richness
Sex 0.950 0.920
Age 0.160 0.233
CFTR mutation N/A N/A
P. aeruginosa 0.011* 0.009*
S. pneumoniae 0.062 0.035*
M. catarrhalis 0.843 0.825
S. aureus 0.583 0.606
H. influenzae 0.307 0.465
The CFTR mutation category was Not Applicable (N/A) as all but one patient was F508del homozygous.
* Discrete variables that passed the Adonis test (p,0.05).
doi:10.1371/journal.pone.0109798.t003
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Phylochip is capable of detecting .50,000 bacterial taxa with high-specificity
probe sets. In this analysis, responsive probes were grouped into ‘‘probe sets’’
empirically based on both correlations in fluorescence intensities across all
biological samples and the taxonomic relatedness of the probe sequences. This is a
more conservative method for annotating taxa and reduces the likelihood of
diversity overestimation. We then annotated empirical OTUs according to a
recently described taxonomic hierarchy [34]. Numerous methods were included
in this study to limit the erroneous identification of OTUs (S1 File:
Supplementary Methods). Despite this caution should be taken when interpreting
results and drawing final conclusions from phylochip data as for all other
metagenomic techniques.
Many of the bacterial taxa detected by the phylochip in this study have not been
classified down to the species and genera levels, with many eOTUs being reported
as unclassified at these levels. Because two thirds of the 16S sequences in GenBank
are only classified to the Kingdom level, other 16S databases such as the
Ribosomal Database Project, SILVA and Greengenes [35] (used in this study),
have emerged to classify a higher proportion of 16S sequences. However many
sequences still remain unclassified. Additionally, grouping of rOTUs into eOTUs
based on taxonomic relatedness and fluorescence similarities across the sample set
further reduces our ability to identify most eOTUs down to the species or genus
level. For these reasons, taxonomic resolution using 16S rRNA-based techniques
can be limiting and obtaining culture data alongside new molecular techniques,
such as 16S rRNA microarrays and 454 sequencing, is of great value.
One of the key strengths of this study lies in the patient selection. The children
with CF were clinically stable, unlike other studies looking at lower airway
infection in CF where samples are collected during exacerbations or when
individuals were clinically unwell. Considering this and the inclusion of a control
group in this study, our results reveal fundamental disruptions in the early CF
airway microbial community. Our study used bronchoscopy and BAL (considered
the reference standard technique) to detect organisms in the lower airway of
patients with CF. In addition we employed a stringent protocol designed to limit
contamination from the upper airway. Few studies have investigated the microbial
community of the CF lower airway and even fewer have reported on the lower
airway microbiota of children without CF. Our control group consisted of
children presenting with a prior history of isolated haemoptysis or stridor,
without current symptoms and a subsequently discovered normal differential cell
count in their BAL sample. It is a limitation of our study that our control cohort
had a history of significant respiratory symptoms to the extent that they required
a bronchoscopy. Despite this, we described patterns in the microbiomes that were
distinct between the two cohorts. We acknowledge that the patient cohorts in this
study are small however statistically significant conclusions were reached. Our
data is cross-sectional, and so we cannot comment on the development of the
microbial community over time. Further longitudinal studies on larger cohorts of
children with CF will be of great benefit to our understanding of the CF airway
microbial community and its involvement in disease progression.
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This study contributes to the current knowledge of microbial communities in
the airways of children with CF. We have highlighted the existence of a sizeable
microbial community in the airways of control children and outlined key
differences between this airway microbiome and that of the CF airway. Further
studies are required to understand how changes in the CF airway microbial
community impact on the airway environment and how this influences lung
physiology and ultimately clinical status.
Supporting Information
S1 File. Supplementary Methods.
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S2 File. The 237 taxa of significantly differential abundance between the control
and CF lower airways using the Welch test (p,0.05).
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S3 File. Permutations of sample group assignments for each factor in 100
FilterFactors, red is the true value. Each open circle represents a randomized
permutation performed. The x-axis explains the number of randomised
permutations performed and the y-axis represents the number of taxa passing the
test (significantly differential abundance). Black circles represent the number of
taxa found to be differential by randomized permutations and the red circle
represents the number of taxa found to be differential by the original Welch test.
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S4 File. The 58 taxa present in .30% of one category and present in none of the
samples from the other category.
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